MIT President Warns of Declining Scientific Optimism Amid Funding Cuts

5 min read

✦

Reader Poll

What do you think about the current state of scientific research funding?

It needs more supportIt's adequate as isIt's too much fundingNot sure

Connecting to poll...

Most successful scientists are optimists. They have to be, since the vast majority of experiments fail. In graduate school, I remember sitting in the lab at Rockefeller University in New York at 3 a.m., surrounded by stacks of culture dishes for growing cancer cells, none quite showing me what I hoped to find. But glimmers of interesting changes in the cells promised future success and made me feel the experiments wanted to work. That optimism drove me to keep trying. One day, they did work and I uncovered a new insight about a process in those cancer cells that no one had described before. In 2026, there seem to be plenty of good reasons to be optimistic about science: Breakthroughs are everywhere. At a recent dinner, the woman next to me glowed with so much energy that I was surprised to learn that she had been diagnosed five years ago with metastatic breast cancer. How had she done so well? She said she moved from one clinical trial to the next, following each new advance in the science — from therapies targeted against her general cancer type, to ones tailored to the genetic mutation that triggered her tumor, to therapies that unleashed her own immune system to fight the cancer. A death sentence turned into a manageable condition — thanks to the continuous investment in scientific discovery. Or take the case of baby KJ Muldoon. A genetic mutation produced a defect in KJ’s metabolism, leading to a toxic buildup of ammonia. The technology called CRISPR made it possible to snip out the bad genetic information, replace it with a segment of the normal gene and save KJ’s life: the first person to be treated with this remarkable new therapy. And now, patients with pancreatic cancer, among the swiftest and most lethal of all cancers, at last have real hope for extending their lives, thanks to novel drugs that target the cancer cells in ways long thought to be impossible. These miraculous treatments came from decades of discovery science: what I call “curiosity on a mission.” Immunotherapies are possible today only because thousands of scientists, for more than 40 years, followed their curiosity to probe the immune system’s deep processes. CRISPR therapies came from scientists determined to understand how bacteria defend themselves from viruses — not from a directed effort to save babies with grave mutations. The promising new treatment for cancer of the pancreas exploits insights into underlying cancer mechanisms initially uncovered 45 years ago at MIT. And far beyond the life sciences — in chemistry, physics, astronomy, AI, quantum computing and more — equally remarkable new discoveries, innovations, and tools are paving the way for decisive leaps. Then why are so many optimistic scientists now losing heart? Because the nation’s research enterprise is shrinking. Scientific funding is drying up. And the funds Congress recently allocated for science are not actually flowing — an unexplained trend lost in the noise of other news. At public and private universities across the country, high-impact science is being damaged and derailed. Speaking for my own institution, compared to this time last year, MIT has experienced a decline in campus research activity funded by federal awards of more than 20%. There’s also damage to the pipeline of talent. Uncertain federal funding means that next year, MIT may have about 500 fewer graduate students helping us to push the scientific frontier and preparing to contribute to society as scientists, inventors, designers, and entrepreneurs. MIT is one of the most influential and productive research communities in the world — truly a national asset. This erosion of our strength is a loss for the nation. The return-on-investment for research and development is remarkable. Shrinking the pipeline of basic discovery research means choking off the flow of future solutions, innovations, and cures — and shrinking the supply of future scientists. Should we as a nation shrug and just let that happen, when China has now passed the United States as the largest global funding source of research and development for the very first time? Some argue that industry can pick up the slack. Since our founding, MIT has worked enthusiastically with industry on applied technical research. But today’s breakthrough advances grew from years of curiosity-driven forays, pushing through a maze of possibilities until the right door swung open. Whose shareholders would back decades of that kind of open-ended exploration without the certainty of commercial returns for the company in question? Philanthropy is equally unable to replace steady federal funding at scale. So let me say it as clearly as I can: Without basic scientific research, supported by the kind of farsighted public investment that allows large-scale, undirected, curiosity-driven inquiry, the scientific pipeline will run dry. In daily life, people may not feel the effects right away, or even in 10 years. But we will feel it. And when someone we love needs therapies that could have emerged but didn’t or when other countries now investing in science can launch new science-based industries or run their societies on vast resources of fusion energy or reap the benefits of quantum computing power or advanced medical breakthroughs, America will wish it sustained its leadership in scientific research here and now. Sally Kornbluth is the president of MIT.

OpinionscienceAI-Enhanced

May 27, 2026

MIT President Warns of Declining Scientific Optimism Amid Funding Cuts

Opinion: MIT president: Why so many optimistic scientists are losing heart

Stat

·5 min read·Sally Kornbluth Massachusetts Institute of Technology

Opinion: MIT president: Why so many optimistic scientists are losing heart

Image: Stat

💡 In a Nutshell

Sally Kornbluth, president of the Massachusetts Institute of Technology, expresses concern over the decline in federal funding for scientific research, which threatens the progress made in various fields, including cancer treatment and genetic therapies. Despite recent breakthroughs, the shrinking research enterprise may hinder future innovations and the development of new therapies.

◆🔑 Key Points

01MIT has seen a more than 20% decline in federally funded research activity compared to last year.
02The U.S. has been surpassed by China as the largest global funding source for research and development.
03Basic scientific research is crucial for long-term innovations, which cannot be fully supported by industry or philanthropy.
04The decline in research funding threatens the pipeline of future scientists, with MIT potentially losing about 500 graduate students.
05Curiosity-driven research has historically led to significant breakthroughs in various scientific fields, including cancer therapies.

In-Article Ad

✎📝 Full Summary

In an opinion piece, Sally Kornbluth, president of the Massachusetts Institute of Technology (MIT), highlights a troubling trend in the scientific community: a decline in optimism among scientists due to shrinking federal funding for research. Despite remarkable advancements in fields like cancer treatment and genetic therapies, Kornbluth warns that the current funding crisis could stifle future innovations. MIT has experienced a more than 20% drop in federally funded research activities compared to the previous year, which could result in a loss of approximately 500 graduate students crucial for scientific progress. Kornbluth emphasizes that curiosity-driven research has historically paved the way for breakthroughs, but without substantial public investment, the scientific pipeline risks running dry. She argues that the consequences of this decline may not be immediately felt, but will ultimately impact society when new therapies and innovations are needed. The article calls for a renewed commitment to supporting basic scientific research to maintain the U.S.'s leadership in global science and technology.

In-Article Ad

##️⃣ Key Figures

20%

Decline in federally funded research activity at MIT compared to last year

500

Potential number of graduate students MIT may lose due to uncertain federal funding

!❗ Why It Matters

The decline in federal funding for scientific research could lead to fewer innovations and therapies, affecting healthcare and technological advancements.

👥 Who is affected

Future scientists, patients requiring new therapies, and society at large.

ℹ️ What to know

Increased public investment in basic scientific research is essential to maintain the U.S.'s leadership in science.

In-Article Ad

?❓ FAQ

Curiosity-driven research has led to significant breakthroughs in various fields, including cancer treatments and genetic therapies, by allowing scientists to explore without the constraints of immediate commercial returns.

Federal funding for scientific research has been declining, with MIT reporting a more than 20% decrease in federally funded research activity compared to the previous year.

✦

Reader Poll

Advanced AnalyticsAnalytics

What do you think about the current state of scientific research funding?

It needs more supportIt's adequate as isIt's too much fundingNot sure

Connecting to poll...

More about Massachusetts Institute of Technology

Ten from MIT accept 2026 Fulbright awards

Ten MIT Affiliates Awarded Fulbright Grants for Global Research

Massachusetts Institute Of Technology • May 27, 2026

¿Un auto eléctrico ya puede ser más barato que uno a gasolina? Estudio del MIT derriba varios mitos

Autos eléctricos: ¿Son más económicos que los de gasolina? Un estudio del MIT lo confirma

El Comercio Perú • May 25, 2026

The role genetically engineered mice could play in fighting Lyme disease

Genetically Engineered Mice: A New Approach to Combat Lyme Disease

Cbs News • May 25, 2026

MIT President Warns of Declining Scientific Optimism Amid Funding Cuts

Reader Poll

More to Explore

Discovery of Plumadraco bankoorum: A Unique Cretaceous Bird with Extraordinary Tail Feathers

Chandrayaan-2 Discovers Water-Ice Beneath Moon's South Pole

ISRO's Chandrayaan-2 Reveals Evidence of Subsurface Ice at Lunar South Pole

MIT President Warns of Declining Scientific Optimism Amid Funding Cuts

Reader Poll

More about Massachusetts Institute of Technology

Related Stories

Discovery of Plumadraco bankoorum: A Unique Cretaceous Bird with Extraordinary Tail Feathers

Chandrayaan-2 Discovers Water-Ice Beneath Moon's South Pole

ISRO's Chandrayaan-2 Reveals Evidence of Subsurface Ice at Lunar South Pole

FAA Grounds SpaceX's Starship V3 Following Launch Mishap

Princeton's Simon Levin Joins Prestigious Royal Society as Fellow

Popular Topics

🔔 Never Miss a Story